Our SVP of Product, Mike Gelber, recently participated in solli’s “Innovation in 2025” roundtable alongside leaders from Bayer, Dermavant Sciences, an Organon company, Novo Nordisk, Genco Pura Media LLC, CMI Media Group and PulsePoint.
The agenda tackled some of the most pressing and exciting topics shaping our industry:
– Real-world applications and ethical boundaries of AI
– Personalization as a value driver, not just a tactic
– The changing nature of HCP and patient interactions
– Operationalizing innovation through collaboration
– Inclusion, access, and purpose-driven planning
– Turning discussion into action
Mike brought a sharp perspective on how we can move from ideation to implementation—especially when it comes to building ethical, scalable, and human-centered AI solutions.
Download the full report from solli and watch the roundtable highlights here.
